Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?
about
Blood CEA levels for detecting recurrent colorectal cancerSerum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancerTumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinomaPersistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinomaCarcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and AutophagyThe Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper[Analysis of histoprognostic factors for the non metastatic rectal cancer in a west Algerian series of 58 cases].Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer.Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer.Measuring quality of care in the treatment of colorectal cancer: the moffitt quality practice initiative.Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.Prognostic factors related with survival in patients with pancreatic adenocarcinomaAnalysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer.Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.The prognostic significance and treatment modality for elevated pre- and postoperative serum CEA in colorectal cancer patientsNeoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors.CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.Factors that influence survival in unresectable metastatic or locally advanced colorectal cancer.Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients.Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer.A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis.Perioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer.
P2860
Q24186921-8DC98262-E1AA-4500-A3E3-A79861F80ECBQ28202441-846E0AE4-4957-4753-8850-94D9AF626996Q33350682-C6DF6D37-2B30-4261-855E-2BD290813FD8Q33494978-89E49B37-5024-4213-9808-78AD3101406CQ33868300-54252D9A-5B6E-4D53-BA3C-EE973F482451Q34605362-16767EA9-5EED-431B-84AE-93E7A202903DQ34608433-449C4F6B-599F-4516-B2E0-193924B5F051Q36337238-C51456FA-115B-47FD-A40D-D91BA259ED33Q36764924-99FFD1D6-5C88-4444-99DF-2C67AA49CBFCQ36793155-47065DE1-9033-40FD-9BAA-32AEFE18D528Q37099595-1D4C3FED-B602-45BB-B950-3F92F4FB436DQ37132759-D98EB075-8269-4376-9AC9-B01D969E7D9FQ37192344-68D54153-33E1-4D3D-8078-14657BC6264AQ37433728-CB5C1672-2313-482F-B7A2-E81E4121334EQ37441231-BCC43105-6812-40BC-9290-666F2845219BQ37476540-3E0FD008-E9B6-4AD8-94C2-891CA71761B1Q38081362-EA6592DA-8A7C-42FE-863D-5689FE82B246Q38242807-ABBBBD00-A83A-4B1E-9372-4441B42E5EF3Q38836105-F11029D5-AE5C-45AE-8B93-4A49A3F8F7D7Q38945257-50AF60B2-6070-44FC-A9D4-4EEFAC6E8CEDQ40363878-62AC3E64-04ED-48AD-BE80-71921F6D3696Q40366923-0E9971A4-A6C8-4A06-8C7D-17B16A6A9296Q41461399-2479B95B-5CC8-4613-AC17-927275A1D972Q42121875-4A633C23-C2EF-4947-8D93-947CFB602FFDQ48139229-669E46F0-49CB-446A-97BD-8953BE5439C2Q48870943-E8C527BB-E191-4E78-93A1-1BA9CDDC70E4Q50919391-C9398B2E-7BB1-4ACC-ABDA-FD419748DA7FQ51032719-69B622E0-AECD-42E2-8C7E-569E5CD77647Q53481924-D6A60A3D-E076-4025-90CA-D45170605892Q55455144-AD82036D-15C7-4BC1-A61E-F490432D6811
P2860
Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Should carcinoembryonic antige ...... tients with colorectal cancer?
@ast
Should carcinoembryonic antige ...... tients with colorectal cancer?
@en
type
label
Should carcinoembryonic antige ...... tients with colorectal cancer?
@ast
Should carcinoembryonic antige ...... tients with colorectal cancer?
@en
prefLabel
Should carcinoembryonic antige ...... tients with colorectal cancer?
@ast
Should carcinoembryonic antige ...... tients with colorectal cancer?
@en
P356
P1476
Should carcinoembryonic antige ...... tients with colorectal cancer?
@en
P2093
Carriquiry LA
P2888
P304
P356
10.1007/BF02237104
P577
1999-07-01T00:00:00Z
P6179
1019726805